FDAnews Device Daily Bulletin

SURMODICS LICENSES HYDROPHILIC COATING FOR THE DEVAX AXXESS DRUG-ELUTING BIFURCATION STENT DELIVERY SYSTEM

April 19, 2006
A A

SurModics, a leading provider of surface modification and drug delivery technologies to the healthcare industry, today announced that its advanced Hydrophilic Technology has been licensed to Devax, Inc. to provide the lubricious coating on its AXXESS Biolimus A-9 Eluting Bifurcation Stent delivery system.
SurModics